MARKET INDEX
KOSPI5,067.44▲ 1.99%
KOSDAQ662.81▼ 0.43%
S&P 5007,303.98▼ 0.50%
NASDAQ24,322.71▼ 0.02%
USD/KRW1,332.32▼ 2.38 (-0.18%)
WTI Crude$82.94▼ 2.02%
BTC/USD$63,122▼ 2.70%
KOSPI5,067.44▲ 1.99%
KOSDAQ662.81▼ 0.43%
S&P 5007,303.98▼ 0.50%
NASDAQ24,322.71▼ 0.02%
USD/KRW1,332.32▼ 2.38 (-0.18%)
WTI Crude$82.94▼ 2.02%
BTC/USD$63,122▼ 2.70%
헤더 좌
헤더 우
BREAKING
MARKET Times 공식 배너

HLB Innovation’s Verismo Therapeutics Secures Stanford’s In Vivo CAR-T Technology

HLB Innovation subsidiary Verismo Therapeutics has licensed Stanford’s PACK-IT technology to develop in vivo CAR-T therapies, aiming to reduce manufacturing costs.

HLB Innovation’s Verismo Therapeutics Secures Stanford’s In Vivo CAR-T Technology
MTIMES Archive / Photo

HLB Innovation subsidiary Verismo Therapeutics has licensed Stanford’s PACK-IT technology to develop in vivo CAR-T therapies, aiming to reduce manufacturing costs.

MARKET Times

MTIMES Global Editorial Statement

This analysis is provided for international business intelligence and informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities. For inquiries regarding licensing or syndication, please contact [email protected].

← More in CorporateBack to Top ↑

Related Market & Corporate Intelligence

Foreigners sell, individuals buy... Matong 44 trillion, anti-trading increases 3 timesForeigners sell, individuals buy... Matong 44 trillion, anti-trading increases 3 timesSamsung and SK Hynix Face Antitrust Scrutiny in U.S. Over DRAM Supply StrategiesSamsung and SK Hynix Face Antitrust Scrutiny in U.S. Over DRAM Supply StrategiesGlobal Oil Market Divergence: Crude Surplus Meets Persistent Diesel TightnessGlobal Oil Market Divergence: Crude Surplus Meets Persistent Diesel TightnessFed's Warsh Warns of Employment Shocks Amid AI Growth ExpectationsFed's Warsh Warns of Employment Shocks Amid AI Growth Expectations
HomeTOP10AlmatenPicksCorpAlgiten